Skip to main content
letter
. 2020 May 25;190(1):e5–e8. doi: 10.1111/bjh.16785

Table I.

Clinical and biological characteristics of patients diagnosed with haematological disorders.

Gender (M/F) Age (years) Date of diagnosis Swabs for COVID‐19 testing after diagnosis (number/result) Diagnosis Molecular and/or cytogenetics WBC/μl at baseline Estimated days of symptoms before going to the emergency room Symptoms before diagnosis Comorbidities associated with HL at diagnosis Follow‐up
F 57 03/17/2020 2/negative Blast crisis in chronic myeloid leukaemia

P190 BCR/ABL

t(9;22)

299 000 23 Weakness, diffuse purpura, conjunctivitis Acute kidney failure (creatinine value: 8–6 mg/l) Death after two days of salvage haemodialysis
F 65 03/18/2020 2/negative Acute myeloid leukaemia

NPM1

46XX

326 000 27 Fever unresponsive to antibiotics, hypoacusia Infective lung nodule (9 × 5 cm), severe respiratory insufficiency On induction chemotherapy after 3 weeks of i.v. antibiotics and antifungal therapy
M 71 03/22/2020 2/negative Mantle cell lymphoma t(11;14) 190 000 45 Low‐grade fever, night sweats, intermittent abdominal pain Bowel sub‐occlusion, spleen infarction On chemotherapy after 2 weeks of surgical surveillance
M 74 04/03/2020 3/negative Acute lymphoblastic leukaemia 46XY 137 000 33 Weakness, persistent low‐grade fever, sore throat Acute kidney failure (creatinine value: 4·6 mg/l), gram positive sepsis On induction chemotherapy after 2 weeks of salvage haemodialysis and 2 weeks of i.v. antibiotics
M 65 04/09/2020 2/negative Acute myeloid leukaemia

FLT3 ITD and FLT3 TKD

46XY

86 000 35 Persistent low‐grade fever, pain on right lower limb associated with initial claudication Pneumonia, superficial thrombosis of femoral arteries On treatment with i.v. antibiotics and anticoagulant therapy (chemotherapy not yet started)
F 65 04/14/2020 3/negative Acute myeloid leukaemia

FLT3 ITD and NPM1

46XX

95 000 42 Fever unresponsive to antibiotics, persistent cough Interstitial pneumonia On treatment with i.v. antibiotics (chemotherapy not yet started)
F 63 04/20/2020 2/negative Blast crisis in chronic myeloid leukaemia

P190 BCR/ABL

t(9;22); +8 in 4 metaphases

77 000 21 Fever unresponsive to antibiotics Pneumonia On treatment with i.v. antibiotics (chemotherapy not yet started)
F 51 04/22/2020 2/negative Accelerated phase in chronic myeloid leukaemia

P210 BCR/ABL

t(9;22)

175 000 33 Weakness, fever unresponsive to antibiotics Pneumonia On treatment with i.v. antibiotics (chemotherapy not yet started)

M, male; F, female; WBC, white blood cells; HL, hyperleukocytosis; i.v., intravenous.